Skip to content

SaCoVLM™ Video Laryngeal Mask Versus LMA Supreme

The Comparison of SaCoVLM™ Video Laryngeal Mask and LMA Supreme in Terms of Oropharyngeal Leak Pressure

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06245668
Enrollment
180
Registered
2024-02-07
Start date
2024-04-01
Completion date
2024-12-25
Last updated
2024-12-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, Airway

Keywords

Supraglottic airway device

Brief summary

Our study aimed to compare two different laryngeal masks, SaCoVLM™ Video Laryngeal Mask and blind placement with LMA Supreme, in adult patients undergoing short elective surgeries. The aim is to optimize the use of commonly used laryngeal masks in clinical practice and examine the differences in oropharyngeal leak pressures.

Detailed description

Laryngeal masks are alternative airway devices commonly used in anesthesia, serving both spontaneously breathing and ventilated patients. LMA Supreme, a second-generation laryngeal mask, has been widely used in routine anesthesia practices and short-duration procedures in our clinic. The advantage of second-generation masks is the presence of gastric access pathways, allowing for additional decompression of the stomach. SaCoVLM™ Video Laryngeal Mask also features a gastric access pathway. Placement of laryngeal masks requires attention to the anatomical features of the airway. Unsuccessful placement of a laryngeal mask can lead to issues such as throat pain, hoarseness, difficulty swallowing, airway obstruction, or leakage, as well as an increase in intragastric pressure due to gastric distention. Our research is a prospective, randomized, controlled method study.The aim in this study is to reveal most accurate placement technique and device to transfer this method to clinical applications. Patients will be evaluated in two groups. Group 1: Placement with SaCoVLM™ video laryngeal mask Group 2: Placement of the LMA Supreme with standard technique After LMA Supreme and SaCoVLM™ video laryngeal mask placement, airway sealing pressures will be measured with appropriate technique. Airway tightness pressure measurement will be made with the technique accepted in the literature through the sensors in the anesthesia machine.

Interventions

The SaCoVLM™ video laryngeal mask will be placed directly into the hypopharyngeal space until resistance is felt, following the recommended instructions for use.

The LMA Supreme will be inserted directly by hand and placed into the hypopharyngeal space until resistance is felt, as per the recommended instructions for use.

Sponsors

Ondokuz Mayıs University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

Sealed opaque envelopes containing study participation numbers will be used to assign each patient. A researcher not involved in patient follow-up will use the web-based Research Randomizer ('Urbaniak and Plous 2013') tool to give each participation number to a random group with a 1:1 ratio. A nurse not an active investigator in the study will have each participant choose an envelope containing the study participation number. They will inform the anesthetist who will administer the methods which group the patient is in immediately before administration. Researchers, patients, surgeons, and nurses will not be aware of the randomization of groups.

Intervention model description

A block randomization list will be created by a doctor who does not participate in patient follow-up using a web-based program, 'Research Randomizer ('Urbaniak and Plous 2013')'.

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Age 18-80 years * BMI \< 35 kg/m2 * ASA (American Society of Anesthesiologists) physical score I/II * Elective surgeries lasting less than 90 minutes

Exclusion criteria

* Patients who are expected to have a difficult airway * Those with potential risk of regurgitation (severe reflux, presence of hiatal hernia) * Those who will undergo head and neck surgery, laparoscopic surgery * Those who will undergo surgery in the prone position * Emergency surgical interventions * Those requiring muscle relaxants * Presence of oral abscess, pharyngeal pathology * Those who have had an upper or lower respiratory tract infection in the last 4 weeks * History of allergy to medications used * Failure to obtain the consent of patients or their families

Design outcomes

Primary

MeasureTime frameDescription
Oropharyngeal leak pressureImmediately after the laryngeal mask is placed, before start of surgeryOropharyngeal leak pressure (OLP) will be measured by closing the adjustable pressure limiting valve on the anesthesia machine. The fresh gas flow was adjusted to 4 L/min. When the APL (Adjustable pressure limiting) valve was closed and manually ventilated. The leak sound that occurs during ventilation will be auscultated. The first peak airway pressure at which the leak occurs will be recorded as the oropharyngeal leak pressure. After successful insertion, laryngeal mask location will be evaluated with fiberoptic imaging.

Secondary

MeasureTime frameDescription
Peak Inspratuar Pressure and Plato PressureIntraoperative periodPeak Inspratuar Pressure and Plato Pressure will be measured after the OLP measurement
Insertion timeProcedure (Time from LMA handling to first wave formation in capnography, assessed from the initiation of LMA handling until the detection of the first capnography wave.)Insertion time will be the time between picking up the device and successful placement
Number of attempts to place the deviceIntraoperative periodNumber of attempts needed for successful placement will be recorded.
Assessment of Glottis Visualization ScoresIntraoperative period after the LMA insertionThis will be assessed using five stages; Stage 1: Vocal cords not visible. Stage 2: Vocal cords and anterior epiglottis visible. Stage 3: Vocal cords and posterior epiglottis visible. Stage 4: Only vocal cords visible.
Heart ratePreoperatively, one minute after the induction, fifth minute and before removed laryngeal mask.Heart rate will be measured in beats per minute with an electrocardiography monitor.
Peripheral oxygen saturationPreoperatively, one minute after the induction, fifth minute and before removed laryngeal mask.Peripheral oxygen saturation per minute will be measured by pulse oximetry
ComplicationsIntraoperative and postoperative day 1.The presence of complications that may be encountered after LMA removal will be investigated (Cough, Bucking, Laryngospasm, Aspiration, Desaturation(SpO2%\< 90%), Need airway assist device(Nasal or oral airway), Blood on the surface of the cuff, hoarseness,sore throat)
Blood pressurePreoperatively, one minute after the induction, fifth minute and before removed laryngeal mask.Non-invasive blood pressure will measure blood pressure in millimeters of mercury.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026